Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | PARPYnD | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | 1 uM | |||||
Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
Quantitative Method |
TMT
|
|||||
Competitor Name | Olaparib | Competitor Info | ||||
Competitor Concentration | 5 uM | |||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Breast | ||||
Disease Model | Breast adenocarcinoma [ICD-11:2C60] | |||||
Model Name | Human breast adenocarcinoma cells (MDA-MB-468) | |||||
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP13240 | Poly [ADP-ribose] polymerase 2 (PARP2) | 3.0 | ||||
LDTP02375 | Poly [ADP-ribose] polymerase 1 (PARP1) | 2.8 | ||||
LDTP13282 | Prenylcysteine oxidase 1 (PCYOX1) | 1.9 | ||||
LDTP04183 | Lanosterol synthase (LSS) | 1.8 | ||||
LDTP04051 | Nicotinamide phosphoribosyltransferase (NAMPT) | 1.5 | ||||
LDTP06375 | Delta(24)-sterol reductase (DHCR24) | 1.5 |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP03798 | Monocarboxylate transporter 8 (SLC16A2) | 2.3 |